Search by Drug Name or NDC
NDC 00178-0745-01 URIBEL TABS 9; .12; 81.6; 10.8; 36.2 mg/1; mg/1; mg/1; mg/1; mg/1 Details
URIBEL TABS 9; .12; 81.6; 10.8; 36.2 mg/1; mg/1; mg/1; mg/1; mg/1
URIBEL TABS is a ORAL TABLET, COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Mission Pharmacal Company. The primary component is BENZOIC ACID; HYOSCYAMINE SULFATE; METHENAMINE; METHYLENE BLUE; PHENYL SALICYLATE.
Product Information
| NDC | 00178-0745 |
|---|---|
| Product ID | 0178-0745_0b25f1da-cbe8-e206-e063-6394a90a4e2e |
| Associated GPIs | |
| GCN Sequence Number | 060244 |
| GCN Sequence Number Description | methenam/m.blue/salicyl/hyoscy TABLET 81.6-0.12 ORAL |
| HIC3 | W2G |
| HIC3 Description | ANTIBIOTIC, ANTIBACTERIAL, MISC. |
| GCN | 26339 |
| HICL Sequence Number | 033419 |
| HICL Sequence Number Description | METHENAMINE/METHYLENE BLUE/BENZOIC ACID/SALICYLAT/HYOSCYAMIN |
| Brand/Generic | Generic |
| Proprietary Name | URIBEL TABS |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Methenamine, Benzoic Acid, Phenyl Salicylate, Methylene Blue, and Hyoscyamine Sulfate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, COATED |
| Route | ORAL |
| Active Ingredient Strength | 9; .12; 81.6; 10.8; 36.2 |
| Active Ingredient Units | mg/1; mg/1; mg/1; mg/1; mg/1 |
| Substance Name | BENZOIC ACID; HYOSCYAMINE SULFATE; METHENAMINE; METHYLENE BLUE; PHENYL SALICYLATE |
| Labeler Name | Mission Pharmacal Company |
| Pharmaceutical Class | Ammonium Ion Binding Activity [MoA], Nitrogen Binding Agent [EPC], Oxidation-Reduction Activity [MoA], Oxidation-Reduction Agent [EPC] |
| DEA Schedule | n/a |
| Marketing Category | UNAPPROVED DRUG OTHER |
| Application Number | n/a |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00178-0745-01 (00178074501)
| NDC Package Code | 0178-0745-01 |
|---|---|
| Billing NDC | 00178074501 |
| Package | 100 TABLET, COATED in 1 BOTTLE (0178-0745-01) |
| Marketing Start Date | 2023-11-07 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |